268 related articles for article (PubMed ID: 9824391)
1. Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease.
Kanazawa H; Shoji S; Yoshikawa T; Hirata K; Yoshikawa J
Clin Exp Allergy; 1998 Oct; 28(10):1244-50. PubMed ID: 9824391
[TBL] [Abstract][Full Text] [Related]
2. Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease.
Rutgers SR; van der Mark TW; Coers W; Moshage H; Timens W; Kauffman HF; Koëter GH; Postma DS
Thorax; 1999 Jul; 54(7):576-80. PubMed ID: 10377200
[TBL] [Abstract][Full Text] [Related]
3. Exhaled nitric oxide--is it really a good marker of airway inflammation in bronchial asthma?
Tsujino I; Nishimura M; Kamachi A; Makita H; Munakata M; Miyamoto K; Kawakami Y
Respiration; 2000; 67(6):645-51. PubMed ID: 11124647
[TBL] [Abstract][Full Text] [Related]
4. Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.
Keatings VM; Collins PD; Scott DM; Barnes PJ
Am J Respir Crit Care Med; 1996 Feb; 153(2):530-4. PubMed ID: 8564092
[TBL] [Abstract][Full Text] [Related]
5. [The levels and clinical implications of induced sputum interleukin-17 in chronic obstructive pulmonary disease and asthma].
Shen F; Zhao MW; He B; Wang YZ; Yao WZ
Zhonghua Nei Ke Za Zhi; 2004 Dec; 43(12):888-90. PubMed ID: 15730730
[TBL] [Abstract][Full Text] [Related]
6. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of nitric oxide derivatives in induced sputum in patients with asthma.
Kanazawa H; Shoji S; Yamada M; Fujii T; Kawaguchi T; Kudoh S; Hirata K; Yoshikawa J
J Allergy Clin Immunol; 1997 May; 99(5):624-9. PubMed ID: 9155829
[TBL] [Abstract][Full Text] [Related]
8. Role of sputum differential cell count in detecting airway inflammation in patients with chronic bronchial asthma or COPD.
Ronchi MC; Piragino C; Rosi E; Amendola M; Duranti R; Scano G
Thorax; 1996 Oct; 51(10):1000-4. PubMed ID: 8977600
[TBL] [Abstract][Full Text] [Related]
9. Exhaled nitric oxide correlated with induced sputum findings in COPD.
Silkoff PE; Martin D; Pak J; Westcott JY; Martin RJ
Chest; 2001 Apr; 119(4):1049-55. PubMed ID: 11296168
[TBL] [Abstract][Full Text] [Related]
10. Role of endogenous nitric oxide in exercise-induced airway narrowing in patients with bronchial asthma.
Kanazawa H; Hirata K; Yoshikawa J
J Allergy Clin Immunol; 2000 Dec; 106(6):1081-7. PubMed ID: 11112890
[TBL] [Abstract][Full Text] [Related]
11. Effect of short-term NO2 exposure on induced sputum in normal, asthmatic and COPD subjects.
Vagaggini B; Paggiaro PL; Giannini D; Franco AD; Cianchetti S; Carnevali S; Taccola M; Bacci E; Bancalari L; Dente FL; Giuntini C
Eur Respir J; 1996 Sep; 9(9):1852-7. PubMed ID: 8880102
[TBL] [Abstract][Full Text] [Related]
12. Airway inflammation in COPD assessed by sputum levels of interleukin-8.
Yamamoto C; Yoneda T; Yoshikawa M; Fu A; Tokuyama T; Tsukaguchi K; Narita N
Chest; 1997 Aug; 112(2):505-10. PubMed ID: 9266891
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of the increased peak levels of exhaled nitric oxide in patients with bronchial asthma.
Satouchi M; Maeda H; Yu Y; Yokoyama M
Intern Med; 1996 Apr; 35(4):270-5. PubMed ID: 8739780
[TBL] [Abstract][Full Text] [Related]
14. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease.
Papi A; Romagnoli M; Baraldo S; Braccioni F; Guzzinati I; Saetta M; Ciaccia A; Fabbri LM
Am J Respir Crit Care Med; 2000 Nov; 162(5):1773-7. PubMed ID: 11069811
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide metabolites in induced sputum: a marker of airway inflammation in asthmatic subjects.
Jang AS; Choi IS; Lee S; Seo JP; Yang SW; Park KO; Lee KY; Lee JU; Park CS; Park HS
Clin Exp Allergy; 1999 Aug; 29(8):1136-42. PubMed ID: 10457119
[TBL] [Abstract][Full Text] [Related]
16. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.
Jatakanon A; Lim S; Kharitonov SA; Chung KF; Barnes PJ
Thorax; 1998 Feb; 53(2):91-5. PubMed ID: 9624291
[TBL] [Abstract][Full Text] [Related]
17. Analysis of plasma-protein leakage and local secretion in sputum from patients with asthma and chronic obstructive pulmonary disease.
Schoonbrood DF; Lutter R; Habets FJ; Roos CM; Jansen HM; Out TA
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1519-27. PubMed ID: 7952610
[TBL] [Abstract][Full Text] [Related]
18. Comparison of alveolar nitric oxide concentrations using two different methods for assessing small airways obstruction in asthma.
Kobayashi D; Tochino Y; Kanazawa H; Ichimaru Y; Kyoh S; Asai K; Hirata K
Respirology; 2011 Jul; 16(5):862-8. PubMed ID: 21564400
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function.
Balzano G; Stefanelli F; Iorio C; De Felice A; Melillo EM; Martucci M; Melillo G
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1486-92. PubMed ID: 10556110
[TBL] [Abstract][Full Text] [Related]
20. Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways.
Ichinose M; Sugiura H; Yamagata S; Koarai A; Shirato K
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):701-6. PubMed ID: 10934109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
